scholarly journals STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-δ12,14-prostaglandin J2 in Triple Negative Breast Cancer

2021 ◽  
Vol 26 (3) ◽  
pp. 207-217
Author(s):  
Su-Jung Kim ◽  
Nam-Chul Cho ◽  
Young-Il Hahn ◽  
Seong Hoon Kim ◽  
Xizhu Fang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Potential Target ◽  
Prostaglandin J2

scholarly journals Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

2018 ◽  
Vol 68 ◽  
pp. 102-110 ◽  
Author(s):  
L. Gerratana ◽  
D. Basile ◽  
G. Buono ◽  
S. De Placido ◽  
M. Giuliano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Androgen Receptor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Potential Target

scholarly journals The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

2018 ◽  
Vol 20 (1) ◽  
Author(s):  
Anjana Bhardwaj ◽  
Harpreet Singh ◽  
Celestine Marie Trinidad ◽  
Constance T. Albarracin ◽  
Kelly K. Hunt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Mevalonic Acid ◽  
Potential Target ◽  
Mevalonic Acid Pathway ◽  
Acid Pathway

CD109 is a potential target for triple-negative breast cancer

Tumor Biology ◽  
2014 ◽  
Vol 35 (12) ◽  
pp. 12083-12090 ◽  
Author(s):  
Ji Tao ◽  
Hongbin Li ◽  
Qingwei Li ◽  
Yu Yang
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Potential Target

scholarly journals Estrogen receptor-beta is a potential target for triple negative breast cancer treatment

Oncotarget ◽  
2018 ◽  
Vol 9 (74) ◽  
pp. 33912-33930 ◽  
Author(s):  
David Austin ◽  
Nalo Hamilton ◽  
Yahya Elshimali ◽  
Richard Pietras ◽  
Yanyuan Wu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Treatment ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Estrogen Receptor Beta ◽  
Breast Cancer Treatment ◽  
Potential Target ◽  
Receptor Beta

scholarly journals Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target

2018 ◽  
Vol 25 (2) ◽  
pp. 856-867 ◽  
Author(s):  
Thomas Grellety ◽  
Celine Callens ◽  
Elodie Richard ◽  
Adrien Briaux ◽  
Valérie Vélasco ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Androgen Receptor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Abiraterone Acetate ◽  
Potential Target
Sign in / Sign up

Export Citation Format

Share Document